gyki 52466 and Chronic Disease
gyki 52466 has been researched along with Chronic Disease in 2 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kim, JE | 1 |
Park, H | 1 |
Lee, JE | 1 |
Kim, TH | 1 |
Kang, TC | 1 |
Farley, S | 1 |
Apazoglou, K | 1 |
Witkin, JM | 1 |
Giros, B | 1 |
Tzavara, ET | 1 |
Other Studies
2 other studies available for gyki 52466 and Chronic Disease
Article | Year |
---|---|
PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats.
Topics: Animals; Benzodiazepines; Chronic Disease; Down-Regulation; Epilepsy; Hippocampus; Male; Models, Bio | 2020 |
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodiazepines; Chronic Disease; Depression; Depr | 2010 |